Scientific article

Hybrid PET-MRI in Alzheimer's Disease Research

Published inMethods in Molecular Biology, vol. 1750, p. 185-200
Publication date2018

Multiple factors, namely amyloid, tau, inflammation, metabolic, and perfusion changes, contribute to the cascade of neurodegeneration and functional decline occurring in Alzheimer's disease (AD). These molecular and cellular processes and related functional and morphological changes can be visualized in vivo by two imaging modalities, namely positron emission tomography (PET) and magnetic resonance imaging (MRI). These imaging biomarkers are now part of the diagnostic algorithm and of particular interest for patient stratification and targeted drug development.In this field the availability of hybrid PET/MR systems not only offers a comprehensive evaluation in a single imaging session, but also opens new possibilities for the integration of the two imaging information. Here, we cover the clinical protocols and practical details of FDG, amyloid, and tau PET/MR imaging as applied in our institutions.

Citation (ISO format)
MAINTA, Ismini Charis et al. Hybrid PET-MRI in Alzheimer’s Disease Research. In: Methods in Molecular Biology, 2018, vol. 1750, p. 185–200. doi: 10.1007/978-1-4939-7704-8_12
Main files (1)
Article (Published version)
ISSN of the journal1064-3745

Technical informations

Creation05/12/2018 8:19:00 PM
First validation05/12/2018 8:19:00 PM
Update time03/15/2023 8:15:51 AM
Status update03/15/2023 8:15:51 AM
Last indexation01/17/2024 2:54:19 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack